These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 15773962

  • 1. Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round.
    Bemelman F, Yong SL, Tissingh R, Schellekens P, ten Berge I.
    Transpl Int; 2005 Apr; 18(4):423-8. PubMed ID: 15773962
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S, Kim JC, Whitaker-Menezes D, Murphy GF, Friedman TM, Korngold R.
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [Abstract] [Full Text] [Related]

  • 5. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y, Ksander BR, Streilein JW.
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [Abstract] [Full Text] [Related]

  • 6. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z, Sproule TJ, Roopenian DC, Ksander AB.
    Transplantation; 2003 Apr 27; 75(8):1368-74. PubMed ID: 12717232
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Major histocompatibility complex class I presentation of exogenously acquired minor alloantigens initiates skin allograft rejection.
    Oukka M, Galou M, Belkaid Y, Tricotet V, Riche N, Reynes M, Kosmatopoulos K.
    Eur J Immunol; 1997 Dec 27; 27(12):3499-506. PubMed ID: 9464840
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K, Hori J, Kagaya F, Usui T, Amano S, Oshika T, Mizouchi T, Tsuru T, Yamagami S.
    Exp Eye Res; 2000 Jun 27; 70(6):737-43. PubMed ID: 10843778
    [Abstract] [Full Text] [Related]

  • 13. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique.
    Fan X, Tyerman K, Ang A, Koo K, Parameswaran K, Tao K, Mai L, Lang H, West LJ.
    Transplant Proc; 2005 Jun 27; 37(1):29-31. PubMed ID: 15808536
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue.
    Wang YC, Mayne A, Sell KW, Ahmed-Ansari A.
    Transplantation; 1990 Aug 27; 50(2):313-24. PubMed ID: 2200176
    [Abstract] [Full Text] [Related]

  • 16. Induction of tolerance across major barriers using a two-step method with genetic analysis of tolerance induction.
    Mayumi H, Good RA.
    Immunobiology; 1989 Mar 27; 179(1):86-108. PubMed ID: 2659501
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Linked suppression of skin graft rejection can operate through indirect recognition.
    Wise MP, Bemelman F, Cobbold SP, Waldmann H.
    J Immunol; 1998 Dec 01; 161(11):5813-6. PubMed ID: 9834057
    [Abstract] [Full Text] [Related]

  • 20. Establishment of a novel method to induce tolerance in adult mice across fully allogeneic (entire H-2 plus multiminor histocompatibility) antigen barriers, using supralethal irradiation followed by injection of syngeneic bone marrow cells plus (donor X recipient) F1 spleen cells.
    Tomita Y, Himeno K, Mayumi H, Tokuda N, Nomoto K.
    Immunobiology; 1989 Jun 01; 179(2-3):214-29. PubMed ID: 2793203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.